Rupa Parvataneni1, Ramon Barajas1, Annette Molinaro2, Gabriela Bourne1, Emma Essock-burns1, Joanna Phillips3, Soonmee Cha1, Susan Chang2, Sarah Nelson1, 4
1Radiology and Biomedical Imaging , University of California, San Francisco, CA, United States; 2Neurosurgery, University of California, San Francisco, CA, United States; 3Pathology, University of California, San Francisco, CA, United States; 4Bioengineering and Therapeutic Sciences, University of California, San Francisco
The purpose of this study was to obtain image guided tissue samples from regions of suspected tumor in untreated GBM patients and compare ex vivo histopathology features with in vivo imaging biomarkers in order to characterize enhancing (CE) versus non enhancing (NE) tumor. Our study showed that DSC imaging parameters were associated with more malignant histology for CE regions, while DWI parameters were associated with more malignant histology in regions of NE tumor. These results are particularly important in delineating tumor margins during the initial surgical resection and in determining the optimal therapeutic interventions during subsequent stages of the disease.